Evidence map›Paper›PMID 25278826›Full record

ArticleFrontiers in neuroscience2014

Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma.

Christine M Dengler-Crish, Matthew A Smith, Denise M Inman, Gina N Wilson, Jesse W Young, Samuel D Crish

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The role of RGC degeneration in the pathogenesis of glaucoma.International journal of biological sciences · 2025
    Review
  8. Article
  9. Article
  10. The Fibro-Inflammatory Response in the Glaucomatous Optic Nerve Head.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Axonal Transport Defects in Retinal Ganglion Cell Diseases.Advances in experimental medicine and biology · 2023
    Review
  13. Review
  14. The Role of Axonal Transport in Glaucoma.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christine M Dengler-CrishDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA ; Department of Anatomy and Neurobiology, Northeast Ohio Medical University Rootstown, OH, USA.
Matthew A SmithDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA ; Integrated Pharmaceutical Medicine Graduate Program, Northeast Ohio Medical University Rootstown, OH, USA.
Denise M InmanDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA.
Gina N WilsonDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA ; Biomedical Sciences Graduate Program, Kent State University Kent, OH, USA.
Jesse W YoungDepartment of Anatomy and Neurobiology, Northeast Ohio Medical University Rootstown, OH, USA.
Samuel D CrishDepartment of Pharmaceutical Sciences, Northeast Ohio Medical University Rootstown, OH, USA.

Funding

Axonopathy in GlaucomaR01EY022358 · NEI · NORTHEAST OHIO MEDICAL UNIVERSITY · PI CRISH, SAMUEL D · 2012 to 2016
$1.9M
NEI NIH HHS R01 EY022358
6 · The paper itself

Abstract

Axonal transport deficits have been reported as an early pathology in several neurodegenerative disorders, including glaucoma. However, the progression and mechanisms of these deficits are poorly understood. Previous work suggests that anterograde transport is affected earlier and to a larger degree than retrograde transport, yet this has never been examined directly in vivo. Using combined anterograde and retrograde tract tracing methods, we examined the time-course of anterograde and retrograde transport deficits in the retinofugal projection in pre-glaucomatous (3 month-old) and glaucomatous (9-13 month old) DBA/2J mice. DBA/2J-Gpnmb (+) mice were used as a control strain and were shown to have similar retinal ganglion cell densities as C57BL/6J control mice-a strain commonly investigated in the field of vision research. Using cholera toxin-B injections into the eye and FluoroGold injections into the superior colliculus (SC), we were able to measure anterograde and retrograde transport in the primary visual projection. In DBA/2J, anterograde transport from the retina to SC was decreased by 69% in the 9-10 month-old age group, while retrograde transport was only reduced by 23% from levels seen in pre-glaucomatous mice. Despite this minor reduction, retrograde transport remained largely intact in these glaucomatous age groups until 13-months of age. These findings indicate that axonal transport deficits occur in semi-functional axons that are still connected to their brain targets. Structural persistence as determined by presence of estrogen-related receptor beta label in the superficial SC was maintained beyond time-points where reductions in retrograde transport occurred, also supporting that transport deficits may be due to physiological or functional abnormalities as opposed to overt structural loss.

Indexed as

axonal transportaxonopathyglaucomaneurodegenerationocularoptic nervesuperior colliculivision disorders

Identifiers

PMID25278826
PMCPMC4166356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.